Skip to search formSkip to main contentSkip to account menu

Esophageal neoplasm metastatic

Known as: metastatic esophageal cancer, esophageal cancer, metastatic, Stage IV Esophageal Cancer 
Stage IV includes: For squamous cell carcinoma: Any T, Any N, M1, Any G, Tumor location: Any. For adenocarcinoma: Any T, Any N, M1, Any G. M1… 
National Institutes of Health

Related topics

Related topics

11 relations
Epithelial CellsEpitheliumEpithelium of esophagusEsophagus

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Clinical Observation of Bevacizumab Combined with S-1 in the Treatment of Pretreated Advanced Esophageal Carcinoma.
Highly Cited
2010
Highly Cited
2010
Cetuximab as Second-Line Therapy in Patients with Metastatic Esophageal Adenocarcinoma: A Phase II Southwest Oncology Group Study (S0415)
Introduction: Esophageal adenocarcinomas commonly express the epidermal growth factor receptor. This trial assessed the 6-month… 
2010
2010
Predictors of Failure of the Laparoscopic Approach for the Management of Small Bowel Obstruction
Small bowel obstruction (SBO) is a common cause of hospital admission. Our objective is to determine variables that correlate… 
2008
2008
Cetuximab as second-line therapy in patients with metastatic esophageal cancer: A phase II Southwest Oncology Group Study
4536 Background: Survival for patients (pts) with metastatic esophageal cancer is poor, with no established therapy for patients… 
2007
2007
Second-Line Combination Chemotherapy with Docetaxel for Cisplatin-Pretreated Refractory Metastatic Esophageal Cancer: A Preliminary Report of Initial Experience
Background and Aims: Patients with esophageal cancer often develop metastatic disease after esophageal resection and generally… 
2007
2007
Metastatic esophageal tumor from cecal carcinoma.
A 55-year-old man developed progressive dysphagia 14 months after palliative colectomy and subsequent systemic chemotherapy for… 
2003
2003
Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapy
AbstractBackground. No effective treatment for advanced esophageal cancer extending to adjacent organs or associated with distant… 
2003
2003
Phase II Trial of 96-Hour Paclitaxel in Previously Treated Patients with Advanced Esophageal Cancer
Background. A 96-hour infusion schedule of paclitaxel demonstrates tolerability and antitumor activity in lung cancer and breast… 
2003
2003
Phase II study of docetaxel and irinotecan in metastatic or recurrent esophageal cancer: a preliminary report.
The outcomes for patients with metastatic or recurrent esophageal cancer are dismal, with 1-year survival rates of approximately… 
1999
1999
Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer.
Esophageal cancer is a major cause of morbidity and mortality worldwide. Although patients often present with apparently… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)